trial

Augmenting Clozapine With Sertindole - SERCLOZ

NCTId NCT00345982
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by University of Aarhus
Primary completion 2010-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2006-09
Primary completion
2010-09
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Serdolect

Sponsors

University of AarhusLead Sponsor
H. Lundbeck A/SCollaborator

Investigators

1
Jimmi Nielsen, M.D.Principal Investigator

Sites

1 total
Aalborg, Denmark

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2010-09
Status
COMPLETED
relationships
The graph out of here
drug
Serdolect
drug
lead_sponsor
University of Aarhus
company
collaborator
H. Lundbeck A/S
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Jimmi Nielsen, M.D.
person